Beam Therapeutics names Eric Foster chief commercial officer

Reuters2026/09/01 11:03

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Beam Therapeutics appointed Eric Foster as chief commercial officer to lead commercial strategy as programs move toward potential launches.
Foster most recently served as chief commercial officer at Ardelyx.
He previously led Horizon’s gout and ophthalmology units, overseeing franchises with USD 2.75 billion in net sales.
Earlier roles included senior vice president and U.S. general manager at Amgen, sales and marketing leadership at GlaxoSmithKline, roles at Johnson & Johnson.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Beam Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609010700PRIMZONEFULLFEED9818894) on September 01, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Beam Therapeutics names Eric Foster chief commercial officer

You may also like

Crypto prices